PRGO Stock Risk & Deep Value Analysis
Perrigo Company PLC
DVR Score
out of 10
What You Need to Know About PRGO Stock
We analyzed Perrigo Company PLC using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran PRGO through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
PRGO Risk Analysis & Red Flags
What Could Go Wrong
Perrigo's failure to return to consistent organic revenue growth and sustained profitability, coupled with its significant debt load (estimated ~$5.6B total debt as of Q1 2026, per training data), could lead to ongoing financial strain. This would limit its ability to invest in growth initiatives, deleverage its balance sheet, and achieve its turnaround objectives, keeping the stock undervalued.
Risk Matrix
Overall
Aggressive
Financial
High
Market
Medium
Competitive
High
Execution
Medium
Regulatory
Medium
Red Flags
- ⚠
Significant net loss of $398.6 million reported in Q1 2026.
- ⚠
High total debt estimated at approximately $5.6 billion as of Q1 2026, relative to a $1.5 billion market cap.
- ⚠
Q2 2026 EPS estimates trimmed by Zacks Research to $0.30 from $0.45.
- ⚠
Lack of clear, disruptive growth drivers or expanding competitive advantages for 10x potential.
- ⚠
Analyst consensus moved to 'Hold' from previously mentioned 'Outperform'.
Upcoming Risk Events
- 📅
Q2 2026 Earnings miss (estimated late July/early August 2026): Missing the trimmed EPS estimate of $0.30 or reporting further revenue declines could trigger significant sell-off.
- 📅
Increased competitive pressure from private label brands (ongoing, Q3 2026 onwards): Aggressive pricing or expansion by store brands could further erode Perrigo's market share and margin in an already competitive environment.
When to Reconsider
- 🚪
Exit if quarterly organic revenue decline accelerates beyond -5% YoY for two consecutive quarters.
- 🚪
Sell if debt-to-equity ratio (currently estimated ~3.7-4.0 from Q1 2026 training data) exceeds 5.0 without clear path to reduction.
- 🚪
Exit if the company reports another significant net loss in Q2 2026 or fails to improve free cash flow.
Unlock PRGO Risk Analysis & Red Flags
Create a free account to see the full analysis
Investment Thesis
If Perrigo's ongoing turnaround initiatives lead to a sustained return to positive organic revenue growth, consistent adjusted EPS beats, and significant debt reduction over the next 12-24 months, then the company could re-rate towards a sector-average valuation multiple, potentially reaching $25-30/share. This is bullish because the market is currently pricing in continued struggles and a high debt load, overlooking the potential for improved operational efficiency and deleveraging.
Is PRGO Stock Undervalued?
Unlock the full AI analysis for PRGO
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
PRGO Price Targets & Strategy
12-Month Target
$19.33
Bull Case
$25.00
Bear Case
$8.00
Valuation Basis
Based on 9x forward P/E applied to the FY2026 EPS consensus of $2.12 = $19.08, rounded to analyst average of $19.33
Entry Strategy
Dollar-cost average between $10.50-$11.50, buying on dips near recent support levels, given the current price is $10.83.
Exit Strategy
Take 50% profit at $19.00 (avg. analyst target), consider full exit if fundamental improvements don't materialize. Stop loss at $9.00 (recent lows).
Portfolio Allocation
1-3% for moderate risk tolerance due to turnaround status and limited 10x growth potential.
Price Targets & Strategy
Sign up free to unlock price targets and entry/exit strategies
Is PRGO Financially Healthy?
Profitability
Gross Margin
34.17%
Operating Margin
-36.92%
Net Margin
-43.50%
Return on Equity
-50.65%
Revenue Growth
-3.62%
EPS
$-13.19
Balance Sheet
Current Ratio
2.76
Quick Ratio
1.44
Debt/Equity
1.24
Other
Beta (Volatility)
0.50
Dividend Yield
10.87%
Does PRGO Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Stable to Eroding
Moat Sources
3 Identified
Perrigo benefits from established brands and efficient scale in the self-care market, which provide some customer loyalty and cost advantages. However, the moat is constantly challenged by aggressive private label competition, shifting consumer preferences, and the need for continuous innovation in a mature sector.
Moat Erosion Risks
- •Aggressive expansion and pricing strategies from private label brands.
- •Inability to innovate effectively and launch new products that capture market share.
- •Increasing competitive intensity from larger, more diversified consumer health companies.
PRGO Competitive Moat Analysis
Sign up to see competitive advantages
PRGO Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral (No significant buzz or meme stock characteristics identified in the provided research, suggesting retail sentiment is not a major driver).
Institutional Sentiment
Neutral-Negative (Consensus rating is 'Hold', with one firm trimming its target and another moving to 'Sell'. While institutional ownership is high at 95.91%, this is typical for an established company and does not indicate strong positive sentiment for high growth.)
Insider Activity (Form 4)
Director Orlando D. Ashford exercised 10,669 RSUs and had 5,122 shares withheld for taxes on May 14, 2026. EVP Matthew John Winterman received 22,388 RSUs on May 13, 2026. These are compensation-related equity events, not open-market purchases or sales, and do not signal strong conviction.
Options Flow
Normal options activity (No specific unusual options activity or significant put/call ratio skew was identified in the provided research, suggesting no strong institutional positioning via options.)
Earnings Intelligence
Next Earnings
Estimated late July/early August 2026 (Q2 2026)
Surprise Probability
Medium (Beat Q1 EPS estimates but Q2 EPS consensus has been trimmed, creating uncertainty.)
Historical Earnings Pattern
Based on Q1 2026, an adjusted EPS beat can provide a temporary lift, but a revenue miss or persistent net losses can quickly temper optimism. The stock is likely sensitive to forward guidance and progress on deleveraging.
Key Metrics to Watch
Competitive Position
Top Competitor
Kenvue Inc. (KVUE)
Market Share Trend
Stable to slightly losing (Revenue decline suggests challenges, but specific market share data is not available).
Valuation vs Peers
Likely trades at a discount on a P/E basis relative to peers due to its turnaround status and high debt, despite the implied target price suggesting a forward P/E of 9x.
Competitive Advantages
- •Established brand portfolio in key self-care categories
- •Extensive distribution network in North America and Europe
- •Scale in manufacturing and supply chain
Market Intelligence
Sign up free to unlock sentiment, earnings intel, and peer analysis
What Could Drive PRGO Stock Higher?
Near-Term (0-6 months)
- •Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference presentation (June 9, 2026): Potential to articulate clearer path to profitability or strategic developments.
- •Q2 2026 Earnings Report (estimated late July/early August 2026): Key focus on organic revenue trends, adjusted EPS vs. trimmed $0.30 estimate, and any updates on full-year 2026 outlook reaffirmation.
Medium-Term (6-18 months)
- •Sustained improvement in operating cash flow and free cash flow generation (H2 2026 - H1 2027): Positive FCF trend would signal turnaround effectiveness and deleveraging potential.
- •Strategic portfolio optimization or divestitures (H2 2026 - H2 2027): Streamlining the business could improve margins and focus on higher-growth areas within self-care.
Long-Term (18+ months)
- •Significant debt reduction (FY2027-FY2029): If the company can reduce its ~$5.6B debt significantly, it would free up capital for reinvestment and improve financial health, potentially re-rating the stock to a higher multiple.
- •Market share gains in key self-care categories (FY2028+): Consistent positive organic revenue growth indicating competitive wins in specific North American or European OTC segments, leading to sustained profitability.
Catalysts & Growth Drivers
Sign up free to see growth catalysts
What's the Bull Case for PRGO?
- ✓
Watch quarterly organic revenue growth – a return to positive growth is critical.
- ✓
Monitor operating margin expansion – sustained improvement indicates efficiency gains.
- ✓
Track debt-to-EBITDA ratio – significant reduction signals financial health improvement.
Bull Case Analysis
Sign up free to see the bull case
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How Perrigo Company PLC Makes Money
Perrigo Company PLC is a global consumer health company that develops, manufactures, and distributes a wide range of over-the-counter (OTC) health and wellness products, primarily for the self-care market in North America and Europe. It sells familiar products like pain relievers, cold and flu remedies, digestive health aids, and nutritional supplements, often under private labels for retailers or its own portfolio of established brands. The company generates revenue by selling these essential consumer healthcare goods through a vast network of pharmacies, grocery stores, and mass merchandisers, leveraging efficient manufacturing and supply chains to offer accessible self-care solutions.
Read Full Business Model BreakdownFAQ
What is the DVR Score for Perrigo Company PLC (PRGO)?
As of June 6, 2026, Perrigo Company PLC has a DVR Score of 2.4 out of 10, placing it in the "Risk Trap" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Perrigo Company PLC?
Perrigo Company PLC's market capitalization is approximately $1.5B..
What is the risk level for PRGO stock?
Our analysis rates Perrigo Company PLC's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
Does Perrigo Company PLC pay a dividend?
Yes, Perrigo Company PLC pays a dividend with a current yield of approximately 10.87%.
Is Perrigo Company PLC's revenue growing?
Perrigo Company PLC has reported revenue growth of -3.6%. Revenue has been declining, which warrants closer examination.
Is PRGO stock profitable?
Perrigo Company PLC has a profit margin of -43.5%. The company is currently unprofitable.
How often is the PRGO DVR analysis updated?
Our AI-powered analysis of Perrigo Company PLC is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on June 6, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for PRGO (Perrigo Company PLC) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.